Beta This is a new service and it is still being tested. Tell us about a problem.

Parliament's record since 1997: debates, questions, statements, votes, bills, committees and members' interests

Where MPs Stand

Sourced briefings on the record of Parliament

Life Sciences and the Industrial Strategy

Inquiry by the Science and Technology Committee, 18 July 2017 to 18 July 2017. Its page on the Parliament website.

Reports and responses

Evidence sessions

  • 10 October 2017: Professor Philip Nelson, Chair, Research Councils UK (RCUK)
  • 10 October 2017: Professor Chris Lowe OBE, Emeritus Professor and Director of the Cambridge Academy of Pharmaceutical Sciences, Cambridge University, Professor John Atherton, Pro Vice-Chancellor and Dean of the School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Professor David Price, Vice-Provost, University College London and Professor James Stirling CBE, Provost, Imperial College London
  • 10 October 2017: Dr Annette Bramley, Head of Healthcare Technologies, Engineering and Physical Sciences Research Council (EPSRC), Sir John Savill, Chief Executive, Medical Research Council (MRC), Louise Wren, Policy Adviser, Wellcome Trust and Sir Harpal Kumar, Chief Executive Officer, Cancer Research UK
  • 17 October 2017: Dr Ian Hudson, Chief Executive, Medicines and Healthcare Regulatory Agency (MHRA) and Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence (NICE)
  • 17 October 2017: Mark Campbell CBE, Senior Manager, Randox Laboratories Ltd, Ian Staples, Chief Executive, Matoke Holdings Ltd and Bryn Sage, Chief Executive, Inhealthcare Ltd
  • 17 October 2017: Dave Allen, Senior Vice President, Respiratory Disease R&D, GSK and Menelas Pangalos, Executive Vice President of Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca
  • 24 October 2017: Professor Sir Robert Lechler, President, Academy of Medical Sciences, Professor Joyce Tait, Director of the Innogen Institute at the University of Edinburgh, Royal Society of Edinburgh and Professor Mark Tooley, President of the Institute of Physics and Engineering in Medicine, Royal Academy of Engineering
  • 24 October 2017: Mike Thompson, Chief Executive Officer, Association of the British Pharmaceutical Industry, Nisha Tailor, Head of Policy and Public Affairs, Association of Medical Research Charities and Steve Bates OBE, Chief Executive Officer, BioIndustry Association
  • 24 October 2017: Keith Chantler, Director of Innovation, Manchester University NHS Foundation Trust, Dame Julie Moore, Chief Executive, University Hospitals Birmingham NHS Foundation Trust and Professor Bryan Williams, Director of R&D, University College London Hospitals
  • 31 October 2017: Dr Veronique Birault, Head of Translation, Francis Crick Institute, Dr Simon Boulton, Senior Group Leader, Francis Crick Institute, Dr Kathy Niakan, Group Leader, Francis Crick Institute, Dr Caetano Reis e Sousa, Senior Group Leader, Francis Crick Institute and Professor Charles Swanton, Senior Group Leader, Francis Crick Institute
  • 31 October 2017: Sir Paul Nurse, Director and Chief Executive, Francis Crick Institute
  • 7 November 2017: Dr Ruth McKernan CBE, Chief Executive Officer, Innovate UK, Chris Molloy, Chief Executive Officer, Medicines Discovery Catapult, Keith Thompson, Chief Executive Officer, Cell and Gene Therapy Catapult and Professor Graham Hillier, Strategy and Futures Director, Centre for Process Innovation, High Value Manufacturing Catapult
  • 7 November 2017: Ian Dodge, National Director for Strategy and Innovation, NHS England, Professor Keith McNeil, Chief Clinical Information Officer Health and Social Care, NHS England and Professor Mike Hannay, Managing Director of the East Midlands Academic Health Science Network (AHSN), NHS England
  • 14 November 2017: Dr Mark Hammond, Co-founder, Deep Science Ventures, Dr John Bowler, Fund Manager and Global Sector Specialist with responsibility for the health care sector, Schroders PLC, Dr Peter Hughes, Healthcare Equity Analyst, AXA Framlington Biotech Fund and Dr Andrew Elder, Partner, Albion Capital
  • 14 November 2017: Dr Glenn Crocker MBE, Representative of the UK Science Park Association (UKSPA) and Chief Executive of BioCity Nottingham Ltd, Dr Iain Thomas, Head of Life Sciences, Cambridge Enterprise and Dr Sally Ann Forsyth, Chief Executive Officer, Norwich Research Park
  • 14 November 2017: Professor Jonathan Elliot, Vice-Principal, Research and Innovation, Royal Veterinary College, Dr David Hughes, Head of Global R&D Technology Scouting, Syngenta and Professor Angela Karp, Director for Science Innovation, Engagement and Partnerships, Rothamsted Research
  • 21 November 2017: Sir John Chisholm, Executive Chair, Genomics England and Professor Dame Ottoline Leyser, Fellow, Royal Society
  • 21 November 2017: Professor Chris Whitty, Chief Scientific Adviser, Department of Health, Interim Government Chief Scientific Adviser and Interim Head of Government Science and Engineering Profession and Professor Dame Sally Davies, Chief Medical Officer for England, Department of Health
  • 21 November 2017: The Rt Hon. the Lord Heseltine CH
  • 28 November 2017: Dr Michael Hopkins, Senior Lecturer, Science Policy Research Unit, Sussex University and Professor Andy Westwood, Member, Industrial Strategy Commission, and Professor of Government Practice and Vice Dean of Humanities, University of Manchester
  • 28 November 2017: Erik Nordkamp, Chair, American Pharmaceutical Group, and UK Managing Director, Pfizer, Mark Hicken, Vice Chair, American Pharmaceutical Group, and UK Managing Director, Janssen and Louise Houson, UK Managing Director, MSD
  • 5 December 2017: Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chair, Office for Strategic Coordination of Health Research (OSCHR)
  • 12 December 2017: Professor Sir Mark Walport FRS, CEO designate, UK Research and Innovation (UKRI)
  • 19 December 2017: Professor Tim Evans, National Director of Clinical Productivity, NHS Improvement and Miles Scott, Improvement Director, NHS Improvement
  • 16 January 2018: John Bassett, Policy and Scientific Development Director, Institute of Food Science and Technology, Professor Paul Kellam, Chair-Elect of the Policy Committee, Microbiology Society and Dr Mark Downs CSci FRSB, Chief Executive, Royal Society of Biology
  • 23 January 2018: The Rt Hon the Lord Henley, Parliamentary Under-Secretary of State, Department for Business, Energy and Industrial Strategy (BEIS) and the Lord O'Shaughnessy, Parliamentary Under-Secretary of State, Department of Health and Social Care
  • 13 March 2018: Professor Tony Young, National Clinical Director, Innovation NHS England